457 related articles for article (PubMed ID: 28986019)
41. Alcohol-related chronic exocrine pancreatic insufficiency: diagnosis and therapeutic management. A proposal for treatment by the Italian Association for the Study of the Pancreas (AISP) and the Italian Society of Alcohology (SIA).
Pezzilli R; Caputo F; Testino G; Patussi V; Greco G; Macciò L; Rossin MR; Mioni D; Balbinot P; Gandin C; Zanesini F; Frulloni L; Aricò S; Bottaro LC; Pellicano R; Scafato E;
Minerva Med; 2019 Oct; 110(5):425-438. PubMed ID: 30938130
[TBL] [Abstract][Full Text] [Related]
42. [Low weight at birth in cystic fibrosis and its relationship to insufficiency of the exocrine pancreas].
De Angelis M; Brinciotti R; Bravo E; Antonelli M
Minerva Pediatr; 1983 May; 35(9):437-9. PubMed ID: 6683777
[No Abstract] [Full Text] [Related]
43. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Alkaade S; Vareedayah AA
Am J Manag Care; 2017 Jul; 23(12 Suppl):S203-S209. PubMed ID: 28727474
[TBL] [Abstract][Full Text] [Related]
44. Nutrition management in adults with cystic fibrosis.
Shape JM; Sala MA
Nutr Clin Pract; 2022 Apr; 37(2):256-264. PubMed ID: 35118712
[TBL] [Abstract][Full Text] [Related]
45. Nutritional management of cystic fibrosis patients.
Kalnins D; Durie PR; Pencharz P
Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):348-54. PubMed ID: 17414506
[TBL] [Abstract][Full Text] [Related]
46. [Mucoviscidosis, a challenging medical problem].
Esedov EM; Gadzhimirzaev GA; Akhmedova FD; Muradova VR; Gadzhimirzaeva RG; Medzhidova RA; Abasova AS
Vestn Otorinolaringol; 2016; 81(5):15-18. PubMed ID: 27876728
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis.
Couper RT; Corey M; Durie PR; Forstner GG; Moore DJ
J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271
[TBL] [Abstract][Full Text] [Related]
48. Assessment of maldigestion in cystic fibrosis.
Walkowiak J
J Pediatr; 2004 Sep; 145(3):285-7. PubMed ID: 15343173
[No Abstract] [Full Text] [Related]
49. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
50. Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency.
Cohen-Cymberknoh M; Simanovsky N; Hiller N; Hillel AG; Shoseyov D; Kerem E
Chest; 2014 Apr; 145(4):738-744. PubMed ID: 24091606
[TBL] [Abstract][Full Text] [Related]
51. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Dorlöchter L; Aksnes L; Fluge G
Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
Nicolo M; Stratton KW; Rooney W; Boullata J
Nutr Clin Pract; 2013 Aug; 28(4):485-9. PubMed ID: 23753650
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic insufficiency in cystic fibrosis: result of defect in ontogenesis of the exocrine pancreas.
Lebenthal E
J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S51-4. PubMed ID: 6502394
[No Abstract] [Full Text] [Related]
54. [Acute pancreatitis in cystic fibrosis].
Vergara M; Puig-Diví V; Guarner L; Malagelada JR
Rev Esp Enferm Dig; 1996 Aug; 88(8):576-9. PubMed ID: 8962766
[TBL] [Abstract][Full Text] [Related]
55. Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis.
Giguere-Rich C; Mathew A; Reid E; Autore K; Guill MF
Nutr Clin Pract; 2018 Apr; 33(2):286-294. PubMed ID: 29658186
[TBL] [Abstract][Full Text] [Related]
56. Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing.
Yuzyuk TN; Nelson HA; Johnson LM
Crit Rev Clin Lab Sci; 2023 Aug; 60(5):366-381. PubMed ID: 36876586
[TBL] [Abstract][Full Text] [Related]
57. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
Lindkvist B; Phillips ME; Domínguez-Muñoz JE
Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
[TBL] [Abstract][Full Text] [Related]
58. Effect of exocrine pancreatic function on resting energy expenditure in cystic fibrosis.
Moudiou T; Galli-Tsinopoulou A; Nousia-Arvanitakis S
Acta Paediatr; 2007 Oct; 96(10):1521-5. PubMed ID: 17880419
[TBL] [Abstract][Full Text] [Related]
59. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
Häusler M; Heimann G; Meilcke R; Biesterfeld S
Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
[No Abstract] [Full Text] [Related]
60. [Physiopathology, diagnosis, and treatment of exocrine pancreatic insufficiency in patients with pancreatic cancer].
Navarro Colás S
Gastroenterol Hepatol; 2005 Feb; 28 Suppl 1():33-8. PubMed ID: 15899236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
